Intima-Media Thickness

Size: px
Start display at page:

Download "Intima-Media Thickness"

Transcription

1 European Society of Cardiology Stockholm, 30th August 2010 Intima-Media Thickness Integration of arterial assessment into clinical practice Prof Arno Schmidt-Trucksäss, MD Institute of Exercise and Health Sciences Medical Faculty, University Basel

2 The Beginning of a Story of Success Pignoli P Circulation Dec;74(6)

3 Original US Image of IMT Arno Schmidt-Trucksäss

4 Risk Factors Correlated With Carotid Atherosclerosis Cholesterol Triglycerides High-density lipoprotein (inverse relationship) Left ventricular mass Electrocardiographic abnormalities Glucose, glucose intolerance Insulin levels Diabetes (especially type 2) Postmenopausal status High-sensitivity C-reactive protein (women) Fibrinogen (men) Advancing age Male gender Blood pressure (especially systolic) Smoking Body mass index Waist-to-hip ratio Low activity level Race, ethnicity Familial history Genetic factors Alcohol consumption Homocysteine Mancini GBJ et al Circulation 2004;109;22-30

5 Risk Factors Correlated With Progression of Carotid Atherosclerosis Arno Schmidt-Trucksäss Age Smoking CAD Hypertension, Pulse pressure Diabetes, disturbed glucose tolerance LDL-cholesterol Oxidized LDL Triglyceride Lipoprotein (a) Fibrinogene Factor V Leiden Leucocyte count Platelet count and aggregability High sensitive CRP Mancini GBJ et al Circulation 2004;109;22-30

6 Prospective Trials with IMT as a Prognostic Marker Authors Study N Age Follow-up Endpoint Measured region Risk assessment Remark Chambless et Fatal or non-fatal cardio-vascular For IMT > 1 vs. < 1 mm, HR adjusted for Diabetes, HDL-, LDLcholesterol, hypertension, smoking, study center, age and race IMT = mean IMT al ARIC Jahre 4-7 years events CCA.,CB,ICA 1.18 ( ) in men and 1.42 ( ) in women of 6 locations Mean 72.5 years 6.2 years MI, stroke, RR for combined endpoint (adjusted for age, gender, blood pressure (sys, dia), smoking (pack years), diabetes, atrial fibrillation) for maximal IMT CCA: 2.22 ( ) for >1.18 mm O Leary et al. at study im combined (highest) vs. <0.87 mm (lowest IMT quintile); 2.47 ( ) for CHS 4476 entry Median endpoint CCA, ICA >1.81 mm (highest) vs. <0.90 mm (lowest IMT quintile) max. IMT Coronary and max. IMT Iglesias del Sol > years cerebrovascular RR 1.41 (95% CI,1.25 bis 1.82) for stroke and 1.43 (95% CI, 1.16 bis separated by et al Rotterdam 1721 years MW disease CCA, CB, ICA 1.78) for MI region years, HR (adjusted for risk factors) for IMTCCA > 0.79mm vs. < 0.63 mm mean MI, stroke, 1.85 ( ), for IMT CB > 0.79mm vs. < 0.63 mm 1.27 (0.80 Lorenz et al years combined 1.99), for IMT ICA > 0.79mm vs. < 0.63 mm 1.25 ( ) for CAPS 5056 years MW endpoint CCA, CB, ICA combinde endpoint mean IMT far wall

7 CIMT of CCA for Prediction of Future Cardiovascular End Points Arno Schmidt-Trucksäss subjects in eight studies followed for 5.5 years (mean) Absolute CIMT difference of 0.1 mm results in an increase of future risk of : 10 15% for myocardial infarction 13 18% for stroke Lorenz et al Circulation Jan 30;115(4)

8 Implementation of Carotid US into Practice American Heart Association Prevention V Conference persons > 50 years of age at intermediate risk for CVD 34th Bethesda Conference persons at intermediate risk for total CVD event risk assessment by CIMT and CAC to assess atherosclerotic burden ESH and ESC CIMT in hypertensive patients better risk stratification, end-organ damage Greenland P et al Circulation. 2001;104: Wilson PWF et al JACC 2003;41: Mancia G et al J Hypertens 2007;25:

9 Added Value in Risk Stratification on Top of Classical Risk Factors Arno Schmidt-Trucksäss At present it seems that the published evidence to quantitatively support the use of a CIMT measurement to help in risk stratification on top of a risk function is limited. Plantinga Y et al Eur J Cardiovasc Prev Rehabil 2009; 16:

10 Variation of IMT with Age Gender Ethnicity Normal values are difficult to provide

11 Parameters Effecting Measurement Variability Training of sonographers Conditions of examination Imaging protocols Reading protocols

12 Parameters Effecting Measurement Variability Training of sonographers Conditions of examination Imaging protocols Reading protocols

13 SAPALDIA (8 study centers) Aarau Payerne Wald Montana

14 Training of Sonographers in SAPALDIA 3 centralized trainings 1-2 individual trainings Certification Regular Re-Certification

15 Parameters Effecting Measurement Variability Training of sonographers Conditions of examination Imaging protocols Reading protocols

16 Ultrasound examination, practical aspects BP 1 lead ECG Blood pressure cuff right upper arm 10 min rest before exam Temperature C Quiet room Half dark Empty bladder Last meal 2 h before Free neck

17 Parameters Effecting Measurement Variability Training of sonographers Conditions of examination Imaging protocols Reading protocols

18 Where to Measure IMT? Thinner Normal Thicker IMT Reduced visibility Increased IMT Good visibility Carotid bulb Common carotid

19 Anatomical Definition of Carotid Regions Bifurcation ICA CCA ECA Tip of flow divider Opening to the bifurcation -landmark frequently not visible in young subjects

20 Measurement Regions Bifurcation US beam ICA CCA ECA distal proximal

21 Visibility of IM Layer in Different Carotid Segments Espeland M 1996 Montabaun v Swijndregt 1999 Riley W 1992 ICA % Bifurcation % CCA % Espeland M et al Stroke 1996; 27: Montabaun van Swijndregt et al Ultrasound Med Biol. 1999; 3: Riley W et al Stroke 1992; 23:

22 Visibility of Near and Far WalI in Different Carotid Segments Arno Schmidt-Trucksäss ICA Bifurcation CCA % % % Near wall Far wall Percentage of walls in which at least one segment was quantified *. N = 899 participants * More than 50% of 17 sites in each segment Espeland M et al Stroke 1994; 25:

23 Variability of IMT Measurement in Different Regions Location Parameter N Intra- Observer Variability (mm) Inter- Observer Variability (mm) CCA distal 1 cm Max IMT ± ±0.26 Mean IMT ± ±0.24 ICA + Bulb Max IMT ± ±0.69 Mean IMT ± ±0.91 O`Leary et al Stroke 1991; 22:

24 IMT Measurement in Prospective Clinical Trials Bifurcation ECA ICA distal CCA proximal Lorenz M et al Circulation Jan 30;115(4):459-67

25 Common Analysed Segment: CCA far Wall Distal 1 cm Bifurcation US Strahl ICA CCA ECA distal proximal

26 Parameters Effecting Measurement Variability Training of sonographers Conditions of examination Imaging protocols Reading protocols

27 How to Analyse the Images? CCA / Bifurcation CCA Cheng D et al Comp Meth Biomed 2002; 67: 27-37

28 IMT Change Across the Heart Cycle CCA IMT CCA Lumen Normal IMT Increased IMT Analysis by A. Teynor

29 % Measurements Arno Schmidt-Trucksäss Distribution of Max IMTmean Around ECG R-peak % at R-peak R -75ms R-50ms R-25ms R R +25ms R +50ms R +75ms Time (ms) 541 patients Mean deviation from IMT at R-peak = 0.06 mm single images (900 images per patient) Haller C et al Atherosclerosis 195 (2007) e203 e209

30 Sequential Automatic Tracing and Analysis XIMT B-mode virtual M-Mode Teynor a et al submitted

31 Examples of Automatic Detection of IMT Carotid Studio B-mode ArtLab RF-based IMT measurement Bianchini E et al J Ultrasound Med 2010; 29:

32 CIMT Measurement as a Screening Tool for the Assessment of the Atherosclerotic Burden Arno Schmidt-Trucksäss High association with atherosclerotic diseases and events Profound training of sonographers and Standardized measurement and reading protocols needed Potential increase of individual clinical significance based on optimal conditions Thank you!

33 Plaque Definition Focal structure Encroachment into lumen of at least 0.5 mm or 50% of surrounding IMT value or Thickness > 1.5 mm

Which CVS risk reduction strategy fits better to carotid US findings?

Which CVS risk reduction strategy fits better to carotid US findings? Which CVS risk reduction strategy fits better to carotid US findings? Dougalis A, Soulaidopoulos S, Cholongitas E, Chalevas P, Vettas Ch, Doumtsis P, Vaitsi K, Diavasti M, Mandala E, Garyfallos A 4th Department

More information

Role of imaging in risk assessment models: the example of CIMT

Role of imaging in risk assessment models: the example of CIMT Role of imaging in risk assessment models: the example of CIMT Diederick E. Grobbee, MD, PhD, FESC Professor of Clinical Epidemiology Julius Center for Health Sciences and Primary Care, University Medical

More information

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.

More information

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti

More information

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries

More information

The presenter does not have any potential conflicts of interest to disclose

The presenter does not have any potential conflicts of interest to disclose Carotid intima-media thickness as a predictor of multi territory atherosclerotic occlusive disease in patients with symptomatic subclavian artery obstruction Leszek Wrotniak 1, Anna Kabłak Ziembicka 1,

More information

ASSOCIATION BETWEEN COMMON CAROTID INTIMA-MEDIA THICKNESS (CAROTID IMT) AND CORONARY ARTERY DISEASE Srinivasa Rao Malladi 1

ASSOCIATION BETWEEN COMMON CAROTID INTIMA-MEDIA THICKNESS (CAROTID IMT) AND CORONARY ARTERY DISEASE Srinivasa Rao Malladi 1 ASSOCIATION BETWEEN COMMON CAROTID INTIMA-MEDIA THICKNESS (CAROTID IMT) AND CORONARY ARTERY DISEASE Srinivasa Rao Malladi 1 HOWTOCITETHISARTICLE: Srinivasa Rao Malladi. Association between Common Carotid

More information

Imaging Biomarkers: utilisation for the purposes of registration. EMEA-EFPIA Workshop on Biomarkers 15 December 2006

Imaging Biomarkers: utilisation for the purposes of registration. EMEA-EFPIA Workshop on Biomarkers 15 December 2006 Imaging Biomarkers: utilisation for the purposes of registration EMEA-EFPIA Workshop on Biomarkers 15 December 2006 Vascular Imaging Technologies Carotid Ultrasound-IMT IVUS-PAV QCA-% stenosis 2 ICH E

More information

Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA

Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA John M. Violanti, PhD* a ; LuendaE. Charles, PhD, MPH b ; JaK. Gu, MSPH b ; Cecil M. Burchfiel, PhD, MPH b ; Michael E. Andrew, PhD

More information

Carotid Ddisease, Carotid IMT and Risk of Stroke

Carotid Ddisease, Carotid IMT and Risk of Stroke Carotid Ddisease, Carotid IMT and Risk of Stroke TATJANA RUNDEK, MD PhD Professor of Neurology, Epidemiology and Public Health Director, Clinical translational Division Department of Neurology, Miller

More information

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD 1 Preclinical? No symptoms No physical findings No diagnostic ECG findings No chest X-ray X findings No diagnostic events 2

More information

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This

More information

Coronary artery disease (CAD) risk factors

Coronary artery disease (CAD) risk factors Background Coronary artery disease (CAD) risk factors CAD Risk factors Hypertension Insulin resistance /diabetes Dyslipidemia Smoking /Obesity Male gender/ Old age Atherosclerosis Arterial stiffness precedes

More information

HDL and Arterial Wall

HDL and Arterial Wall JIFA January 31th 2014 HDL and Arterial Wall P-J TOUBOUL INSERM698 Bichat University Conflict of Interest M Ath intellectual property owner Involvement in R & D for atherosclerosis software developments

More information

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Jamaica At the end of this presentation the participant

More information

How to detect early atherosclerosis ; focusing on techniques

How to detect early atherosclerosis ; focusing on techniques How to detect early atherosclerosis ; focusing on techniques Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon city, S. Korea Surrogates for Atherosclerosis Measures of endothelial

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: carotid_intimal_medial_thickness 12/2006 10/2016 10/2018 10/2017 Description of Procedure or Service Ultrasonographic

More information

surtout qui n est PAS à risque?

surtout qui n est PAS à risque? 3*25 min et surtout qui n est PAS à risque? 2018 ESC/ESH Hypertension Guidelines 2018 ESC-ESH Guidelines for the Management of Arterial Hypertension 28 th ESH Meeting on Hypertension and Cardiovascular

More information

Cho et al., 2009 Journal of Cardiology (2009), 54:

Cho et al., 2009 Journal of Cardiology (2009), 54: Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal

More information

JMSCR Vol 06 Issue 12 Page December 2018

JMSCR Vol 06 Issue 12 Page December 2018 www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.115 Evaluation of Carotid Intima

More information

PATIENTS AND METHODS:

PATIENTS AND METHODS: BACKGROUND: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by erosive synovitis that involves peripheral joints and implicates an important influence in the quality

More information

The association of the total cardiovascular risk and non-invasive markers of atherosclerosis with the extent of coronary artery disease

The association of the total cardiovascular risk and non-invasive markers of atherosclerosis with the extent of coronary artery disease The association of the total cardiovascular risk and non-invasive markers of atherosclerosis with the extent of coronary artery disease S. Kostic 1, D. Mijalkovic 1, D. Djordjevic 2, T. Savic 2, D. Lovic

More information

The Impact of Smoking on Acute Ischemic Stroke

The Impact of Smoking on Acute Ischemic Stroke Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease

More information

MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL

MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL DEFINITION OF A SCREENING TEST TESTING FOR A DISEASE OR CONDITION IN ASYMPTOMATIC PERSONS TO IDENTIFY THE CONDITION BEFORE IT MANIFESTS

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING MEDICAL POLICY PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

Screening for Cardiovascular Risk (2/6/09)

Screening for Cardiovascular Risk (2/6/09) Screening for Cardiovascular Risk (2/6/09) Andrew Nicolaides MS, FRCS, FRCSE, PhD (Hon) Emeritus Professor of Vascular Surgery, Imperial College, London, UK Chairman, Cardiovascular Disease Educational

More information

Prevalence and Significance of Carotid Plaques in Patients With Coronary Atherosclerosis

Prevalence and Significance of Carotid Plaques in Patients With Coronary Atherosclerosis ORIGINAL ARTICLE DOI 10.4070 / kcj.2009.39.8.317 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2009 The Korean Society of Cardiology Prevalence and Significance of Carotid Plaques in Patients

More information

Practical challenges in CV risk management: When to start intervening in CVD?

Practical challenges in CV risk management: When to start intervening in CVD? The National Research Center for Preventive Medicine Ministry of Healthcare, Russian Federation Practical challenges in CV risk management: When to start intervening in CVD? Prof. Drapkina O.M., Eliashevich

More information

The clinical significance of carotid intima-media thickness in cardiovascular diseases: a survey in Beijing

The clinical significance of carotid intima-media thickness in cardiovascular diseases: a survey in Beijing (2008) 22, 259 265 & 2008 Nature Publishing Group All rights reserved 0950-9240/08 $30.00 www.nature.com/jhh ORIGINAL ARTICLE The clinical significance of carotid intima-media thickness in cardiovascular

More information

PULSE WAVE VELOCITY AS A NEW ASSESSMENT TOOL FOR ATHEROSCLEROSIS

PULSE WAVE VELOCITY AS A NEW ASSESSMENT TOOL FOR ATHEROSCLEROSIS PULSE WAVE VELOCITY AS A NEW ASSESSMENT TOOL FOR ATHEROSCLEROSIS Introduction Hirohide Yokokawa, M.D., Ph.D. 1 , Aya Goto, M.D., MPH, Ph.D. 2 , and Seiji Yasumura, M.D., Ph.D.

More information

Atherosclerosis Regression An Overview of Recent Findings & Issues

Atherosclerosis Regression An Overview of Recent Findings & Issues Atherosclerosis Regression An Overview of Recent Findings & Issues 13th Angioplasty Summit 2008 Cheol Whan Lee, MD University of Ulsan, Asan Medical Center, Seoul, Korea CardioVascular Research Foundation

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

Name of Policy: Ultrasonographic Measurement of Carotid Intimal-Medial Thickness as an Assessment of Subclinical Atherosclerosis

Name of Policy: Ultrasonographic Measurement of Carotid Intimal-Medial Thickness as an Assessment of Subclinical Atherosclerosis Name of Policy: Ultrasonographic Measurement of Carotid Intimal-Medial Thickness as an Assessment of Subclinical Atherosclerosis Policy #: 245 Latest Review Date: July 2014 Category: Medicine Policy Grade:

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

CAROTID INTIMA-MEDIA THICKNESS. Dimitrios N. Nikas, MD, PhD, FESC Interventional Cardiologist Ioannina University Hospital

CAROTID INTIMA-MEDIA THICKNESS. Dimitrios N. Nikas, MD, PhD, FESC Interventional Cardiologist Ioannina University Hospital CAROTID INTIMA-MEDIA THICKNESS Dimitrios N. Nikas, MD, PhD, FESC Interventional Cardiologist Ioannina University Hospital I, DIMITRIOS N. NIKAS, MD, PHD, FESC, HAVE NO CONFLICT OF INTEREST TO DECLARE RELATED

More information

Slide notes: References:

Slide notes: References: 1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory

More information

Objective Calcium score carotid IMT hs-crp

Objective Calcium score carotid IMT hs-crp P3952 Role of coronary calcium score, carotid intima-media thickness and C-reactive protein in predicting extent of coronary artery disease in young patients. Bedside Poster P3952 Role of coronary calcium

More information

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Central pressures and prediction of cardiovascular events in erectile dysfunction patients Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,

More information

Asian J. Exp. Sci., Vol. 27, No. 1, 2013; 67-72

Asian J. Exp. Sci., Vol. 27, No. 1, 2013; 67-72 Carotid Intima-media Thickness as a Surrogate Marker of Atherosclerosis and its Correlation with Coronary Risk Factors and Angiographic Severity of Coronary Artery Disease. 1 2 Rajeev Gupta and Rajendra

More information

ARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority:

ARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: ARIC Manuscript Proposal #1233 PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: 1.a. Full Title: Subclinical atherosclerosis precedes type 2 diabetes in the ARIC study cohort

More information

MEDICAL POLICY. 02/15/18 CATEGORY: Technology Assessment

MEDICAL POLICY. 02/15/18 CATEGORY: Technology Assessment MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which

More information

SUPPLEMENTAL MATERIAL. Materials and Methods. Study design

SUPPLEMENTAL MATERIAL. Materials and Methods. Study design SUPPLEMENTAL MATERIAL Materials and Methods Study design The ELSA-Brasil design and concepts have been detailed elsewhere 1. The ELSA-Brasil is a cohort study of active or retired 15,105 civil servants,

More information

Ezetimibe and SimvastatiN in Hypercholesterolemia EnhANces AtherosClerosis REgression (ENHANCE)

Ezetimibe and SimvastatiN in Hypercholesterolemia EnhANces AtherosClerosis REgression (ENHANCE) Ezetimibe and SimvastatiN in Hypercholesterolemia EnhANces AtherosClerosis REgression (ENHANCE) Thomas Dayspring, MD, FACP Clinical Assistant Professor of Medicine University of Medicine and Dentistry

More information

Beyond Framingham: Risk Assessment & Treatment for Primary Prevention

Beyond Framingham: Risk Assessment & Treatment for Primary Prevention Beyond Framingham: Risk Assessment & Treatment for Primary Prevention Ronald M. Goldenberg, MD, FRCPC, FACE Consultant Endocrinologist, North York General Hospital Medical Co-Director, LMC Endocrinology

More information

Glycemic and blood pressure control in older patients with hypertension and diabetes: association with carotid atherosclerosis

Glycemic and blood pressure control in older patients with hypertension and diabetes: association with carotid atherosclerosis Journal of Geriatric Cardiology (2011) 8: 24 30 2011 IGC All rights reserved; www.jgc301.com Research Articles Open Access Glycemic and blood pressure control in older patients with hypertension and diabetes:

More information

STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY. Harvey D White on behalf of The STABILITY Investigators

STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY. Harvey D White on behalf of The STABILITY Investigators STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY Harvey D White on behalf of The STABILITY Investigators Lipoprotein- associated Phospholipase A 2 (Lp-PLA 2 ) activity:

More information

Clinical Investigation and Reports. Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction

Clinical Investigation and Reports. Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction Clinical Investigation and Reports Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction The Rotterdam Study Irene M. van der Meer, MD, PhD; Michiel L. Bots, MD,

More information

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular

More information

Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D.

Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D. Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D. TensioMed Arterial Stiffness Centre, Budapest Heart Institute, Faculty of Medicine, University of Pécs

More information

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life

More information

Estrogens vs Testosterone for cardiovascular health and longevity

Estrogens vs Testosterone for cardiovascular health and longevity Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in

More information

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Quanta Diagnostico Nuclear Curitiba, Brazil Clinical history Male 63 y.o.,

More information

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation 50 YO man NSTEMI treated with PCI 1 month ago Medical History: Obesity: BMI 32,

More information

Individuals of African and African Caribbean descent living

Individuals of African and African Caribbean descent living ORIGINAL RESEARCH A.D. Mackinnon P. Jerrard-Dunne L. Porteous H.S. Markus Carotid Intima-Media Thickness is Greater but Carotid Plaque Prevalence is Lower in Black Compared with White Subjects BACKGROUND

More information

The Diabetes Link to Heart Disease

The Diabetes Link to Heart Disease The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM

More information

ROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret

ROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret ROLE OF INFLAMMATION IN HYPERTENSION Dr Barasa FA Physician Cardiologist Eldoret Outline Inflammation in CVDs the evidence Basic Science in Cardiovascular inflammation: The Main players Inflammation as

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

Flatter Diurnal Cortisol Slope on Workdays is Associated with Pre-clinical Atherosclerosis

Flatter Diurnal Cortisol Slope on Workdays is Associated with Pre-clinical Atherosclerosis Flatter Diurnal Cortisol Slope on Workdays is Associated with Pre-clinical Atherosclerosis Karissa G. Miller, B.A., Thomas W. Kamarck, Ph.D., Matthew F. Muldoon, M.D., Peter J. Gianaros, Ph.D., & Stephen

More information

Dyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram

Dyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram Dyslipidaemia Is there any new information? Dr. A.R.M. Saifuddin Ekram PhD,FACP,FCPS(Medicine) Professor(c.c.) & Head Department of Medicine Rajshahi Medical College Rajshahi-6000 New features of ATP III

More information

Rates and Determinants of Site-Specific Progression of Carotid Artery Intima-Media Thickness. The Carotid Atherosclerosis Progression Study

Rates and Determinants of Site-Specific Progression of Carotid Artery Intima-Media Thickness. The Carotid Atherosclerosis Progression Study Rates and Determinants of Site-Specific Progression of Carotid Artery Intima-Media Thickness The Carotid Atherosclerosis Progression Study Andrew D. Mackinnon, MRCP; Paula Jerrard-Dunne, MRCPI; Matthias

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Ultrasonographic Measurement of Carotid Intimal-Medial Thickness Page 1 of 11 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Ultrasonographic Measurement of Carotid

More information

CardioHealth Station. powered by. Healthcare CardioHealth

CardioHealth Station. powered by. Healthcare CardioHealth CardioHealth Station FDA cleared, in-office ultrasound imaging that helps you directly identify atherosclerotic cardiovascular disease (ASCVD) allowing you to make a more informed decision about your patients

More information

DECLARATION OF CONFLICT OF INTEREST. None

DECLARATION OF CONFLICT OF INTEREST. None DECLARATION OF CONFLICT OF INTEREST None BURDEN OF CORONARY ARTERY DISEASE IN DIABETES IN INDIA Amal Kumar Banerjee MD, DM,FACC,FESC,FACP,FAPSC,FICC President Association of Physicians of India SAARC Cardiac

More information

ARIC Manuscript Proposal # 1036r. PC Reviewed: _07/26/05 Status: D Priority: SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # 1036r. PC Reviewed: _07/26/05 Status: D Priority: SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1036r PC Reviewed: _07/26/05 Status: D Priority: SC Reviewed: Status: Priority: 1.a. Full Title: The Association between Isolated vs Combined Large and Small Artery Disease with

More information

Is the Ankle-Brachial Index a Useful Screening Test for Subclinical Atherosclerosis in Asymptomatic, Middle-Aged Adults?

Is the Ankle-Brachial Index a Useful Screening Test for Subclinical Atherosclerosis in Asymptomatic, Middle-Aged Adults? Is the Ankle-Brachial Index a Useful Screening Test for Subclinical Atherosclerosis in Asymptomatic, Middle-Aged Adults? Rachael A. Wyman, MD; Jon G. Keevil, MD; Kjersten L. Busse, RN, MSN; Susan E. Aeschlimann,

More information

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment

More information

CRP and fibrinogen imply clinical outcome of patients with type-2 diabetes. and coronary artery disease

CRP and fibrinogen imply clinical outcome of patients with type-2 diabetes. and coronary artery disease CRP and fibrinogen imply clinical outcome of patients with type-2 diabetes and coronary artery disease Marijan Bosevski 1, *, Golubinka Bosevska 1, Lily Stojanovska 2, Vasso Apostolopoulos 2, * 1 University

More information

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers CardioMetabolic Risk Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often present long before the diagnosis of type 2 Diabetes. SpectraCell s CardioMetabolic and Pre-Diabetes

More information

ARBITER 6-HALTS HDL And LDL Treatment Strategies

ARBITER 6-HALTS HDL And LDL Treatment Strategies ARBITER 6-HALTS HDL And LDL Treatment Strategies Extended-Release Niacin or Ezetimibe and Carotid Intima Media Thickness Allen J. Taylor, M.D. Todd C. Villines, M.D. Eric J. Stanek, Pharm.D. Patrick J.

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive

More information

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS? HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL

More information

How would you manage Ms. Gold

How would you manage Ms. Gold How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56

More information

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure

More information

Landmesser U et al. Eur Heart J 2017; https://doi.org/ /eurheartj/ehx549

Landmesser U et al. Eur Heart J 2017; https://doi.org/ /eurheartj/ehx549 2017 Update of ESC/EAS Task Force on Practical Clinical Guidance for PCSK9 inhibition in Patients with Atherosclerotic Cardiovascular Disease or in Familial Hypercholesterolaemia Cardiovascular Outcomes

More information

Chapter 08. Health Screening and Risk Classification

Chapter 08. Health Screening and Risk Classification Chapter 08 Health Screening and Risk Classification Preliminary Health Screening and Risk Classification Protocol: 1) Conduct a Preliminary Health Evaluation 2) Determine Health /Disease Risks 3) Determine

More information

CARDIOMETABOLIC SYNDROME

CARDIOMETABOLIC SYNDROME CARDIOMETABOLIC SYNDROME Prof. Gerald Yonga FESC, FACC Dept of Medicine, Aga Khan University East Africa Introduction Years after the term metabolic syndrome was first coined, controversy continues over

More information

Clinical Trial Synopsis TL-OPI-518, NCT#

Clinical Trial Synopsis TL-OPI-518, NCT# Clinical Trial Synopsis, NCT# 00225264 Title of Study: A Double-Blind, Randomized, Comparator-Controlled Study in Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl vs Glimepiride

More information

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised

More information

Methods. Background and Objectives STRADIVARIUS

Methods. Background and Objectives STRADIVARIUS STRADIVARIUS Effect of on Progression of Atherosclerosis in Patients with Abdominal Obesity and Coronary Artery Disease Steven E. Nissen MD Stephen J. Nicholls MBBS PhD, Kathy Wolski MPH, Josep Rodés-Cabau

More information

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA Acute coronary syndrome Dr LM Murray Chemical Pathology Block SA13-2014 Acute myocardial infarction (MI) MI is still the leading cause of death in many countries It is characterized by severe chest pain,

More information

Received: March 2008; in final form May 2008.

Received: March 2008; in final form May 2008. RELATIONSHIP BETWEEN BRACHIAL ARTERY FLOW- MEDIATED DILATION AND CAROTID ARTERY INTIMA MEDIA THICKNESS IN THE MIDDLE-AGED SUBJECTS WITH LOW CARDIOVASCULAR RISK GERMAINE SĂVOIU*, LAVINIA NOVEANU**, O. FIRA-MLADINESCU*,

More information

HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES

HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES A study published in the British Medical Journal shows that not only is high LDL cholesterol not a risk factor for all-caused

More information

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental

More information

Early Detection of Damaged Organ

Early Detection of Damaged Organ Early Detection of Damaged Organ Regional Cardiovascular Center, Chungbuk National University Kyung-Kuk Hwang Contents NICE guideline 2011 - Confirm the diagnosis of HT ambulatory blood pressure monitoring

More information

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension. 2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature

More information

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary

More information

Epidemiologic studies have established a. Risk Factors for Subclinical Carotid Atherosclerosis Among Current Smokers CLINICAL STUDY

Epidemiologic studies have established a. Risk Factors for Subclinical Carotid Atherosclerosis Among Current Smokers CLINICAL STUDY 166 PREVENTIVE CARDIOLOGY FALL 2010 CLINICAL STUDY Risk Factors for Subclinical Carotid Atherosclerosis Among Current Smokers Heather M. Johnson, MD; Megan E. Piper, PhD; Douglas E. Jorenby, PhD; Michael

More information

Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease

Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease D. Dallmeier 1, D. Rothenbacher 2, W. Koenig 1, H. Brenner

More information

Fasting or non fasting?

Fasting or non fasting? Vascular harmony Robert Chilton Professor of Medicine University of Texas Health Science Center Director of Cardiac Catheterization labs Director of clinical proteomics Which is best to measure Lower continues

More information

Blood Pressure Targets in Diabetes

Blood Pressure Targets in Diabetes Stockholm, 29 th August 2010 ESC Meeting Blood Pressure Targets in Diabetes Peter M Nilsson, MD, PhD Department of Clinical Sciences University Hospital, Malmö Sweden Studies on BP in DM2 ADVANCE RCT (Lancet

More information

Is Carotid Intima-Media Thickness Useful in Cardiovascular Disease Risk Assessment? The Rotterdam Study

Is Carotid Intima-Media Thickness Useful in Cardiovascular Disease Risk Assessment? The Rotterdam Study Is Carotid Intima-Media Thickness Useful in Cardiovascular Disease Risk Assessment? The Rotterdam Study Antonio Iglesias del Sol, MD; Karel G.M. Moons, MD, PhD; Monika Hollander, MD; Albert Hofman, MD,

More information

1. Which one of the following patients does not need to be screened for hyperlipidemia:

1. Which one of the following patients does not need to be screened for hyperlipidemia: Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:

More information

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary 2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth

More information

Protokollanhang zur SPACE-2-Studie Neurology Quality Standards

Protokollanhang zur SPACE-2-Studie Neurology Quality Standards Protokollanhang zur SPACE-2-Studie Neurology Quality Standards 1. General remarks In contrast to SPACE-1, the neurological center participating in the SPACE-2 trial will also be involved in the treatment

More information